Canton Strategic Holdings (CNTN) Assets Average (2022 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Assets Average came in at $551.9 million in Q1 2026, up 20405.63% YoY from N/an in Q1 2025, and up 109.51% on a QoQ basis from $263.4 million in Q4 2025.
Analysis
Canton Strategic Holdings (CNTN) Assets Average (2022 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 5 years of Assets Average data on file, last reported at $551.9 million in Q1 2026.
- Quarterly Assets Average rose 20405.63% year-over-year to $551.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $551.9 million (up 20405.63% YoY) and the FY2025 annual result came in at $261.4 million, up 3464.68% from the prior year.
- Assets Average grew to $551.9 million in Q1 2026, from $263.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $551.9 million in Q1 2026 to a low of $2.1 million in Q2 2025.
- A 5-year average of $53.5 million and a median of $6.8 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2025 — Assets Average plunged 75.55% — and 2026, when it surged 20405.63%.
- Tracing CNTN's Assets Average over 5 years: stood at $7.4 million in 2022, then declined by 4.04% to $7.1 million in 2023, then sank by 36.42% to $4.5 million in 2024, then soared by 5771.54% to $263.4 million in 2025, then surged by 109.51% to $551.9 million in 2026.
- The last three Assets Average figures came in at $551.9 million (Q1 2026), $263.4 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.22 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 3.29 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.86 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - | 574.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 574.61 Mn |
| Mar 31, 2026 | 551.90 Mn |
| Dec 31, 2025 | 263.42 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Jun 30, 2024 | 8.57 Mn |
| Mar 31, 2024 | 9.92 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Sep 30, 2023 | 3.88 Mn |
| Jun 30, 2023 | 4.66 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 7.35 Mn |
| Sep 30, 2022 | 9.13 Mn |
| Jun 30, 2022 | 11.17 Mn |
| Mar 31, 2022 | 6.36 Mn |